Novo Nordisk (NVO.N): New doses of its weight loss drug Wegovy have been submitted to the European Medicines Agency for approval. One-third of trial participants achieved a weight loss of 25% or more.

2025-07-08 21:15:01

weight loss drug Novo Nordisk

Email Subscription

Newsletters and emails are now available! Delivered on time, every weekday, to keep you up to date with North American business news.

Weekly Highlights

                                    Oppenheimer: Raises Nvidia (NVDA.O) price target from $175 to $200.
                            2025-07-15

                                    Shanghai: Accelerate the implementation of major engineering projects and build core capabilities of the smart glasses industry
                            2025-07-15

                                    ETF Midday Review: ChiNext Artificial Intelligence ETF Southern led the gains by 4.95%, while the CSI 2000 ETF Fund led the losses by 4.36%
                            2025-07-15

                                    Tesla Model Y long-range rear-wheel drive version is priced at about RMB 567,000 in India
                            2025-07-15

                                    BOE A: Will submit a review to the ITC regarding the preliminary ruling of the 337 investigation on trade secrets
                            2025-07-15